217 related articles for article (PubMed ID: 8176702)
1. Mechanism-based design, synthesis, and in vitro antimalarial testing of new 4-methylated trioxanes structurally related to artemisinin: the importance of a carbon-centered radical for antimalarial activity.
Posner GH; Oh CH; Wang D; Gerena L; Milhous WK; Meshnick SR; Asawamahasadka W
J Med Chem; 1994 Apr; 37(9):1256-8. PubMed ID: 8176702
[No Abstract] [Full Text] [Related]
2. Design, synthesis, derivatization, and structure-activity relationships of simplified, tricyclic, 1,2,4-trioxane alcohol analogues of the antimalarial artemisinin.
Cumming JN; Wang D; Park SB; Shapiro TA; Posner GH
J Med Chem; 1998 Mar; 41(6):952-64. PubMed ID: 9526569
[TBL] [Abstract][Full Text] [Related]
3. Enantiomeric 1,2,4-trioxanes display equivalent in vitro antimalarial activity versus Plasmodium falciparum malaria parasites: implications for the molecular mechanism of action of the artemisinins.
O'Neill PM; Rawe SL; Borstnik K; Miller A; Ward SA; Bray PG; Davies J; Oh CH; Posner GH
Chembiochem; 2005 Nov; 6(11):2048-54. PubMed ID: 16222725
[TBL] [Abstract][Full Text] [Related]
4. [Recent advances in the study of artemisinin-related 1,2,4-trioxanes and ozonides (1,2,4-trioxolanes) as antimalarials].
Yang ZS; Li Y
Yao Xue Xue Bao; 2005 Dec; 40(12):1057-63. PubMed ID: 16496665
[No Abstract] [Full Text] [Related]
5. Antimalarial cyclic peroxy ketals.
Posner GH; O'Dowd H; Ploypradith P; Cumming JN; Xie S; Shapiro TA
J Med Chem; 1998 Jun; 41(12):2164-7. PubMed ID: 9622557
[TBL] [Abstract][Full Text] [Related]
6. Further evidence supporting the importance of and the restrictions on a carbon-centered radical for high antimalarial activity of 1,2,4-trioxanes like artemisinin.
Posner GH; Wang D; Cumming JN; Oh CH; French AN; Bodley AL; Shapiro TA
J Med Chem; 1995 Jun; 38(13):2273-5. PubMed ID: 7608890
[No Abstract] [Full Text] [Related]
7. Design, Synthesis, and Biological Evaluation of Novel 1,2,4-Trioxanes as Potential Antimalarial Agents.
Gupta AK; Varshney K; Kumar V; Srivastava K; Pant AB; Puri SK; Saxena AK
Arch Pharm (Weinheim); 2017 Apr; 350(3-4):. PubMed ID: 28207169
[TBL] [Abstract][Full Text] [Related]
8. A QSAR study of the antimalarial activity of some synthetic 1,2,4-trioxanes.
Grigorov M; Weber J; Tronchet JM; Jefford CW; Milhous WK; Maric D
J Chem Inf Comput Sci; 1997; 37(1):124-30. PubMed ID: 9025258
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antimalarial activity of 2-methoxyprop-2-yl peroxides derivatives.
Cointeaux L; Berrien JF; Peyrou V; Provot O; Ciceron L; Danis M; Robert A; Meunier B; Mayrargue J
Bioorg Med Chem Lett; 2003 Jan; 13(1):75-7. PubMed ID: 12467620
[TBL] [Abstract][Full Text] [Related]
10. Antimalarial activity of artemisinin (qinghaosu) and related trioxanes: mechanism(s) of action.
Cumming JN; Ploypradith P; Posner GH
Adv Pharmacol; 1997; 37():253-97. PubMed ID: 8891104
[No Abstract] [Full Text] [Related]
11. Endoperoxide antimalarials: development, structural diversity and pharmacodynamic aspects with reference to 1,2,4-trioxane-based structural scaffold.
Rudrapal M; Chetia D
Drug Des Devel Ther; 2016; 10():3575-3590. PubMed ID: 27843298
[TBL] [Abstract][Full Text] [Related]
12. Novel spiroanellated 1,2,4-trioxanes with high in vitro antimalarial activities.
Griesbeck AG; El-Idreesy TT; Höinck LO; Lex J; Brun R
Bioorg Med Chem Lett; 2005 Feb; 15(3):595-7. PubMed ID: 15664819
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and in vitro cancer cell growth inhibition evaluation and antimalarial testing of trioxanes installed in cyclic 2-enoate substructures.
Hossain MI; Świtalska M; Peng W; Takashima M; Wang N; Kaiser M; Wietrzyk J; Dan S; Yamori T; Inokuchi T
Eur J Med Chem; 2013 Nov; 69():294-309. PubMed ID: 24056020
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antimalarial activity of some 9-substituted artemisinin derivatives.
Acton N; Karle JM; Miller RE
J Med Chem; 1993 Aug; 36(17):2552-7. PubMed ID: 8355254
[TBL] [Abstract][Full Text] [Related]
15. Orally active, hydrolytically stable, semisynthetic, antimalarial trioxanes in the artemisinin family.
Posner GH; Parker MH; Northrop J; Elias JS; Ploypradith P; Xie S; Shapiro TA
J Med Chem; 1999 Jan; 42(2):300-4. PubMed ID: 9925735
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationships of lactone ring-opened analogs of the antimalarial 1,2,4-trioxane artemisinin.
Posner GH; McGarvey DJ; Oh CH; Kumar N; Meshnick SR; Asawamahasadka W
J Med Chem; 1995 Feb; 38(4):607-12. PubMed ID: 7861408
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and in vitro antimalarial activity of sulfone endoperoxides.
Bachi MD; Korshin EE; Ploypradith P; Cumming JN; Xie S; Shapiro TA; Posner GH
Bioorg Med Chem Lett; 1998 Apr; 8(8):903-8. PubMed ID: 9871509
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationships of the antimalarial agent artemisinin. 2. Effect of heteroatom substitution at O-11: synthesis and bioassay of N-alkyl-11-aza-9-desmethylartemisinins.
Avery MA; Bonk JD; Chong WK; Mehrotra S; Miller R; Milhous W; Goins DK; Venkatesan S; Wyandt C; Khan I
J Med Chem; 1995 Dec; 38(26):5038-44. PubMed ID: 8544180
[TBL] [Abstract][Full Text] [Related]
19. Orally active 1,2,4-trioxanes: synthesis and antimalarial assessment of a new series of 9-functionalized 3-(1-arylvinyl)-1,2,5-trioxaspiro[5.5]undecanes against multi-drug-resistant plasmodium yoelii nigeriensis in mice.
Singh C; Malik H; Puri SK
J Med Chem; 2006 May; 49(9):2794-803. PubMed ID: 16640340
[TBL] [Abstract][Full Text] [Related]
20. Mechanism-based development of new antimalarials: synthesis of derivatives of artemisinin attached to iron chelators.
Kamchonwongpaisan S; Paitayatat S; Thebtaranonth Y; Wilairat P; Yuthavong Y
J Med Chem; 1995 Jun; 38(13):2311-6. PubMed ID: 7608896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
